Hsbc Holdings PLC Sells 86,290 Shares of Corteva, Inc. $CTVA

Hsbc Holdings PLC lowered its stake in shares of Corteva, Inc. (NYSE:CTVA) by 6.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 1,268,478 shares of the company’s stock after selling 86,290 shares during the quarter. Hsbc Holdings PLC’s holdings in Corteva were worth $106,087,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. JPL Wealth Management LLC acquired a new position in Corteva in the 3rd quarter valued at $25,000. Westfuller Advisors LLC grew its holdings in shares of Corteva by 2,764.3% during the 1st quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after purchasing an additional 387 shares in the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of Corteva during the 4th quarter worth $27,000. Bank of Jackson Hole Trust bought a new position in shares of Corteva in the fourth quarter worth $28,000. Finally, Cornerstone Financial Management LLC bought a new position in shares of Corteva in the fourth quarter worth $29,000. Institutional investors own 81.54% of the company’s stock.

Wall Street Analyst Weigh In

CTVA has been the subject of several recent analyst reports. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. Berenberg Bank raised their target price on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. CICC Research boosted their target price on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Mizuho upped their price target on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Finally, BNP Paribas Exane increased their price target on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $88.95.

Corteva Stock Up 0.1%

Shares of CTVA opened at $87.42 on Monday. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $88.22. The stock has a market capitalization of $58.47 billion, a price-to-earnings ratio of 51.43, a PEG ratio of 2.67 and a beta of 0.56. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a fifty day moving average of $80.86 and a 200-day moving average of $78.26.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the business posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.